Role of G1359A polymorphism of the cannabinoid receptor gene on weight loss and adipocytokines levels after two different hypocaloric diets

Journal of Nutritional Biochemistry

Volumn 23, Issue 3, 2012, Pages 287-291

  Antonio de Luis, Daniel ^a   Sagrado, Manuel Gonzalez ^a   Aller, Rocio ^a   Conde, Rosa ^a   Izaola, Olatz ^a   de la Fuente, Beatriz ^a   Primo, David ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adipocytokines; Cannabinoid receptor gene; Low carbohydrate diet; Low fat diet; Obesity

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CANNABINOID 1 RECEPTOR; CARBOHYDRATE; CHOLESTEROL; FAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CYTOKINE RESPONSE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; LOW CALORY DIET; LOW CARBOHYDRATE DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUTRITIONAL ASSESSMENT; OBESITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; WILD TYPE;

ADIPOKINES; ADULT; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; FEMALE; GENOTYPE; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; MUTATION, MISSENSE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTOR, CANNABINOID, CB1; WEIGHT LOSS;

EID: 84856704711     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.12.006     Document Type: Article

References (35)

1. de Luis D.A., Aller R., Izaola O., González Sagrado, Conde R., Perez Castrillon J.L. Effects of lifestyle modification on adipocytokine levels in obese patients. Eur Rev Med Pharmacol Sci 2008, 12:33-39.
2. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999, 58:315-348.
3. Brown S.M., Warger- Miller J., Mackie K. Cloning and molecular characterization of the rat CB2 cannabinoid receptor. Biochim Biophys Acta 2002, 1576:255-264.
4. Fride E. Endocannabinoids in the central nervous system an overview. Prostaglandins Leukot Essent Fatty acids 2002, 66:221-233.
5. Felder C.C., Glass M. Cannabinoid receptors and their endogenous agonists. Ann Rev Pharmacol Toxicol 1998, 38:179-200.
6. Ravinet T.C., Delgorge C., Menet C., Arnone M., Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004, 28:640-648.
7. Gadzicki D., Muller-Vahl K., Stuhrmann M. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Mol Cell Probes 1999, 13:321-323.
8. Duart M.J., Arroyo C.O., Moreno J.L. Validation of a insulin model for the reactions in RIA. Clin Chem Lab Med 2002, 40:1161-1167.
9. Mathews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-414.
10. Lehmann H.P., Block D., Markert-Hahn C., Zolg J.W. New concepts in systemic autoimmunity testing. Scand J Clin Lab Invest Suppl. 2001, 235:84-90.
11. Pfutzner A., Langefeld M., Kunt T., Lobig M. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin lab 2003, 49:571-576.
12. Meier U., Gressner M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, Ghrelin, adiponectin, and resistin. Clin Chem 2004, 50:1511-1525.
13. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 2004, 50:219-221.
14. Lubrano V., Cocci F., Battaglia D., Papa A. Usefulness of high-sensitivity IL6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal 2005, 19:110-114.
15. Khan S.S., Smith M.S., reda D., Suffredini A.F., Mc Coy J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufactures. Cytometry B Clin Cytom 2004, 61:35-39.
16. Feurer I.D., Mullen J.L. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry. Nutr Clin Pract 1986, 1:43-49.
17. Pichard C., Slosman D., Hirschel B., Kyle U. Bioimpedance analysis: an improved method for nutritional follow up. Clin Res 1993, 41:53.
18. Mataix J., Mañas M. Tablas de composición de alimentos españoles 2003, University of Granada.
19. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin. Regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825.
20. Cota D., Genghini S., Pasquali R., Paggoto U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003, 112:423-431.
21. Liu Y.L., Connoley I.P., Wilson C.A., Stock M.J. Effects of the endocannabinoid antagonist SR141716 on oxygen consumption and soleus muscle storage uptake in Lep(ob)/Lep(Ob) mice. Int J Obes Relat Metab Disrd 2005, 29:183-187.
22. Gomez R., Navarro M., Ferrer B. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neuroscie 2002, 22:9612-9617.
23. Engeli S., Jana B., Mareike F., Kerstin G., Jürgen J., Sandor B. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005, 54:2838-2843.
24. Gazzerro P., Caruso M.G., Notarnicola M., Misciagna G., Guerra V., Laezza C., Bifulco M. Association between cannabinoid type 1 receptor polymorphism and body mass index in a southern Italian population. Int J Obes 2007, 31:908-912.
25. Aberle J., Flitsch J., Alessia N., Mann O., Busch P., Peitsmeier P., Ulrich F. Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes. Mol Genet Metab 2008, 95:188-191.
26. Jaeger J., Mattevi V., Callegari-Jacques S.D., Hutz M.H. Cannabinoid type 1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population. Disease Markers 2008, 25:67-74.
27. Russo P., Strazzullo P., Cappuccio F., Tregouet D., Lauria F., Loguercio M., Barba G., et al. Genetic variations at the endocannabinoid type 1 receptor gene (CRN1) are associated with obesity phenotypes in Men. J Clin Endocrinol Metab 2007, 92:2382-2389.
28. Peeters A., Beckers S., Mertens I., Van Hul W., Van Gaal L. The G1422A variant of the endocannabinoid receptor gene is associated with abdominal adiposity in obese men. Endocr 2007, 31:138-141.
29. Jbilo O., Ravinet-Trillou C., Arnone M., Buisson I., Bribes E., Peleraux A. The CB1 receptor antagonist rimonabant reverses the diet induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 2005, 19:1567-1569.
30. Bensaid M., Gary Bobo M., Esclangon A., Maffrand J.P., Le Fur G., Oury-Donat F. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultures adipocyte cells. Mol Pharmacol 2003, 63:908-914.
31. Poirier B., Bidoauard J.P., Cadrouvele C., Marniquet X., Staels B., O'Connor S.E. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes Obes Metab 2005, 7:65-72.
32. Cases J.A., Gabrielly I., Ma X.H. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 2001, 50:348-352.
33. Thanos P.K., Ramalhete R.C., Michelides M., Piyis Y.K., Wang G.J., Volkow N.D. Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions. Synapse 2008, 62:637-642.
34. Malcher Lopes R., Di S., Marcheselli V.S., Weng F.J., Stuart C.T., Bazan N.G., Tasker J.G. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J Neurosci 2006, 26:6643-6650.
35. Monteleone P., Bifulco M., Maina G., Tortorella A., Gazzerro P., Proto M.C., Di Filippo C., Monteleone F., Canestrelli B., Buonerba G., Bogetto F., Maj M. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. Pharmacol Res. 2010, 61(5):400-404.